Updated Recommendation
A new evidence synthesis was published:2016, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
View latest version (2016)Bibliographic information
Recommendation
All pregnant and breastfeeding women living with HIV should initiate triple antiretrovirals (ARV), which should be maintained at least for the duration of risk of mother-to-child transmission. Women meeting treatment eligibility criteria should continue ART for life (CD4 <500 cells/mm3)
Recommended in favor
Strong
Certainty of evidence
Moderate
Also Featured In
This recommendation also appears in the following guidelines:
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations